I.P.O. of Juno Therapeutics, Developer of a Cancer Treatment, Excites Investors
… Dendreon, a company with a prostatecancer therapy that similarly required processing … beyond blood cancers to the solid tumors like lung, breast and prostatecancers, which constitute a majority of cancer …
No comments:
Post a Comment